https://www.cochrane.org/evidence/CD011611_ketamine-and-other-glutamate-receptor-modulators-bipolar-depression
Ketamine and other glutamate receptor modulators for bipolar depression | Cochrane
glutamate receptor modulatorsand otherbipolar depressionketaminecochrane
https://adisinsight.springer.com/drugs/800033300?error=cookies_not_supported&code=8d95fccd-67ee-48d1-9e9d-949b817e6323
Research programme: metabotropic glutamate receptor modulators - Pfizer - AdisInsight
Pfizer is developing oral metabotropic glutamate receptor selective allosteric modulators for the treatment of neurological diseases such as anxiety and
glutamate receptor modulatorsresearch programmepfizeradisinsight